Editorial: COVID-19: From bedside to follow-up.
作者信息
Gunst Jesper Damsgaard, Cajander Sara
机构信息
Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
出版信息
Front Med (Lausanne). 2023 Feb 22;10:1155049. doi: 10.3389/fmed.2023.1155049. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: COVID-19: From bedside to follow-up.社论：2019冠状病毒病：从床边到随访
Front Med (Lausanne). 2023 Feb 22;10:1155049. doi: 10.3389/fmed.2023.1155049. eCollection 2023.
2
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.新冠病毒感染后 15 个月，COVID-19 后急性后遗症（PASC）中 CD16+ 单核细胞中 SARS-CoV-2 S1 蛋白持续存在。
Front Immunol. 2022 Jan 10;12:746021. doi: 10.3389/fimmu.2021.746021. eCollection 2021.
3
[Monitoring the development of post-COVID–19 syndrome].[监测新冠后综合征的发展]
Orv Hetil. 2022 Feb 27;163(9):335-342. doi: 10.1556/650.2022.32432.
4
Monitoring New Symptoms After COVID-19 Infection Among Primary Care Patients in New York City.监测纽约市初级保健患者感染 COVID-19 后的新症状。
J Am Board Fam Med. 2021 Sep-Oct;34(5):1014-1016. doi: 10.3122/jabfm.2021.05.210122.
5
Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol.意大利同一家庭中成人和儿童的新冠后状况：一项使用ISARIC全球随访方案的前瞻性队列研究
Front Pediatr. 2022 Apr 21;10:834875. doi: 10.3389/fped.2022.834875. eCollection 2022.
6
Editorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 Pandemic.社论：儿童中症状性和无症状性 SARS-CoV-2 感染的长期影响以及由 COVID-19 大流行驱动的常见儿童病毒发病机制的变化。
Med Sci Monit. 2022 Aug 1;28:e937927. doi: 10.12659/MSM.937927.
7
Long COVID-19 syndrome as a fourth phase of SARS-CoV-2 infection.新冠长期综合征作为新冠病毒感染的第四阶段。
Infez Med. 2022 Mar 1;30(1):22-29. doi: 10.53854/liim-3001-3. eCollection 2022.
8
Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19.社论：用于 COVID-19 高风险个体的 SARS-CoV-2 暴露后预防中和单克隆抗体。
Med Sci Monit. 2021 Aug 16;27:e934393. doi: 10.12659/MSM.934393.
9
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia.一项在 18-59 岁健康成年人中评估 SARS-CoV-2 灭活疫苗的有效性、安全性和免疫原性的 III 期、观察者盲法、随机、安慰剂对照研究：印度尼西亚的中期分析。
Vaccine. 2021 Oct 22;39(44):6520-6528. doi: 10.1016/j.vaccine.2021.09.052. Epub 2021 Sep 24.
10
Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV.老年人感染 HIV 后接种 COVID-19 疫苗后抗 SARS-CoV-2 刺突蛋白免疫原性的定性评估（QUASI）。
HIV Med. 2022 Feb;23(2):178-185. doi: 10.1111/hiv.13188. Epub 2021 Oct 10.
本文引用的文献
1
Severe SARS-Cov2 pneumonia in vaccinated patients: a multicenter cohort study.接种过疫苗的患者中严重的 SARS-CoV-2 肺炎：一项多中心队列研究。
Sci Rep. 2023 Feb 2;13(1):1902. doi: 10.1038/s41598-023-29131-9.
2
Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE).队列资料简介：丹麦国家 SARS-CoV-2 疫苗效果和安全性队列研究（ENFORCE）。
BMJ Open. 2022 Dec 30;12(12):e069065. doi: 10.1136/bmjopen-2022-069065.
3
Characteristics of a Danish Post-COVID Cohort Referred for Examination due to Persistent Symptoms Six Months after Mild Acute COVID-19.丹麦一个因轻度急性新冠病毒感染后六个月仍有持续症状而被转诊检查的新冠后队列的特征。
J Clin Med. 2022 Dec 10;11(24):7338. doi: 10.3390/jcm11247338.
4
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome.严重急性呼吸综合征冠状病毒 2 变异株对住院临床结局的影响。
Clin Infect Dis. 2023 May 3;76(9):1539-1549. doi: 10.1093/cid/ciac957.
5
Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.与接受美国退伍军人事务部医院治疗的已接种疫苗成年人中 COVID-19 重症相关的因素。
JAMA Netw Open. 2022 Oct 3;5(10):e2240037. doi: 10.1001/jamanetworkopen.2022.40037.
6
Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance.与奥密克戎（B.1.1.529）变异株流行期间住院的实验室确诊 SARS-CoV-2 感染患者死亡相关的危险因素。
Am J Infect Control. 2023 Jun;51(6):603-606. doi: 10.1016/j.ajic.2022.08.033. Epub 2022 Sep 6.
7
Risk stratification in hospitalized COVID-19 patients.住院COVID-19患者的风险分层
J Hepatol. 2021 Sep;75(3):740-742. doi: 10.1016/j.jhep.2021.04.024. Epub 2021 Apr 24.
8
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
9
Age and sex differences in soluble ACE2 may give insights for COVID-19.可溶性血管紧张素转换酶2的年龄和性别差异可能为新冠病毒疾病提供见解。
Crit Care. 2020 May 14;24(1):221. doi: 10.1186/s13054-020-02942-2.
Zotero 插件